Review reveals cd4+ t tissue-resident memory cells enhance immune responses in lungs, indicating their potential in vaccine strategies.
CD4 + tissue‐resident memory T (T RM ) cells are essential for immune protection in the lungs, providing rapid responses against respiratory pathogens. Unlike circulating memory T cells, CD4 + T RM cells persist in the tissue parenchyma and possibly inducible lymphoid tissues, where they facilitate pathogen clearance through cytokine production and interactions with local immune cells. While CD8 + T RM cells are well studied, the role of CD4 + T RM cells in immunity remains less defined and is the focus of this review. Distinct subsets, based on the effector T H 1, T H 2, T H 17 and T follicular helper (T FH )‐like tissue‐resident helper (T RH ) cells, contribute to antiviral, antibacterial, antifungal and vaccine‐induced immunity. CD4 + T RM cells play a key role in infections, enhancing immune responses and supporting antibody production. However, they are also implicated in chronic inflammation, allergies and fibrosis. Given their importance, vaccines aiming to elicit lung‐resident CD4 + T RM cells, particularly via mucosal delivery, have shown promise in inducing long‐term protective immunity. Intranasal vaccination strategies, such as live‐attenuated influenza virus and tuberculosis vaccines, have successfully generated CD4 + T RM cells, highlighting their potential for respiratory pathogen control. In this review, we focus on CD4 + T RM cells, their differentiation, maintenance and role, especially in the lungs.
No takes yet. Share an insight, caveat, or question.
Kirkby et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: